Document is current
Any future updates will be listed below
-
Authors
Grodzki, Marco
Bluhm, Andrew P.
Schaefer, Moritz
Tagmount, Abderrahmane
Russo, Max
Sobh, Amin
Rafiee, Roya
Vulpe, Chris D.
Karst, Stephanie M. https://orcid.org/0000-0003-0406-4637
Norris, Michael H.
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R01AI123144)
University of Florida (Clinical and Translational Science Institute)
- License Information
-
More Information
Article History
Received: 29 October 2021
Accepted: 10 January 2022
First Online: 27 January 2022
Declarations
:
: Not applicable.
: Not applicable.
: A patent entitled “Methods of Treatment for SARS-CoV-2 Infections (PROV Appl. No. 63/145,763)” for use of compounds identified in this paper as COVID treatments was filed on February 4, 2021, with S.M.K, C.D.V., and M.H.N. listed as inventors. The provisional patent was filed after the data in this work were obtained. The remaining authors declare that they have no competing interests.
